Regeneron Momentum Indicators Momentum

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>RP</div>
REGN -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Regeneron Pharmaceuticals momentum-indicators tool provides you with the Momentum Indicators execution environment for running Momentum indicator against Regeneron Pharmaceuticals. Momentum indicators of Regeneron Pharmaceuticals are pattern recognition functions that provide distinct formation on Regeneron Pharmaceuticals potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.
Symbol
Refresh

The output start index for this execution was one with a total number of output elements of sixty. The Momentum indicator shows the difference between current closing price of Regeneron Pharmaceuticals and Regeneron Pharmaceuticals close price N days ago. View also all equity analysis or get more info about momentum momentum indicators indicator.

Additional Technical Research

About Regeneron Pharmaceuticals Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Pharmaceuticals stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Earnings
Estimates (1)
LowProjected EPSHigh
23.8423.8423.84
Details
Hype
Prediction
LowEstimated ValueHigh
583.48587.44656.70
Details
Intrinsic
Valuation
LowReal ValueHigh
538.30542.26656.70
Details
Naive
Forecast
LowNext ValueHigh
607.02610.98614.94
Details
Analysts
Consensus (21)
LowTarget PriceHigh
400.00559.16734.00
Details
 2017 2018 2019 2020 (projected)
Long Term Debt to Equity0.1144930.0809040.0643750.066069
Interest Coverage82.7989.8773.1768.39
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 8030 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Purchased few shares
Active a day ago
Purchased few shares
Active a day ago
Purchased few shares
Active a day ago
Purchased over 50 shares
Active a day ago
Additionally, take a look at Your Equity Center. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page